Le Lézard13 小时
Head-to-Head Preclinical Studies of SFA-002 as a Novel Psoriasis Treatment Presented at the ...
SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic compounds for the treatment ...